TELADOC INC

NYSE: TDOC (Teladoc Health, Inc.)

Last update: 10 Jun, 3:31PM

7.40

0.01 (0.07%)

Previous Close 7.40
Open 7.50
Volume 3,796,046
Avg. Volume (3M) 5,347,066
Market Cap 1,298,219,136
Price / Sales 0.470
Price / Book 0.850
52 Weeks Range
6.35 (-14%) — 15.21 (105%)
Earnings Date 29 Jul 2025 - 4 Aug 2025
Profit Margin -38.96%
Operating Margin (TTM) -6.58%
Diluted EPS (TTM) -5.87
Quarterly Revenue Growth (YOY) -3.00%
Total Debt/Equity (MRQ) 106.27%
Current Ratio (MRQ) 1.77
Operating Cash Flow (TTM) 293.68 M
Levered Free Cash Flow (TTM) 229.78 M
Return on Assets (TTM) -3.30%
Return on Equity (TTM) -52.46%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Bearish Mixed
Health Information Services (Global) Bearish Mixed
Stock Teladoc Health, Inc. Bearish Bearish

AIStockmoo Score

-0.4
Analyst Consensus -0.5
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 1.5
Technical Oscillators -0.5
Average -0.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
TDOC 1 B - - 0.850
MPLN 260 M - - 3.71
AMWL 168 M - - 0.370
VEEV 47 B - 60.59 7.40
DOCS 11 B - 51.68 9.90
PHR 2 B - - 5.41

Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Sector Healthcare
Industry Health Information Services
Investment Style Small Value
% Held by Insiders 0.84%
% Held by Institutions 75.32%

Ownership

Name Date Shares Held
Maple Rock Capital Partners Inc. 31 Mar 2025 3,347,340
52 Weeks Range
6.35 (-14%) — 15.21 (105%)
Price Target Range
7.00 (-5%) — 12.00 (62%)
High 12.00 (Canaccord Genuity, 62.16%) Buy
Median 8.00 (8.11%)
Low 7.00 (B of A Securities, -5.41%) Hold
7.00 (Evercore ISI Group, -5.41%) Hold
Average 8.64 (16.76%)
Total 2 Buy, 7 Hold
Avg. Price @ Call 6.98
Firm Date Target Price Call Price @ Call
B of A Securities 28 May 2025 7.00 (-5.41%) Hold 6.97
11 Apr 2025 8.00 (8.11%) Hold 7.25
Truist Securities 27 May 2025 9.00 (21.62%) Hold 7.08
Wells Fargo 08 May 2025 8.00 (8.11%) Hold 7.08
Canaccord Genuity 01 May 2025 12.00 (62.16%) Buy 6.99
Evercore ISI Group 01 May 2025 7.00 (-5.41%) Hold 6.99
Goldman Sachs 01 May 2025 10.00 (35.14%) Buy 6.99
Stifel 01 May 2025 8.00 (8.11%) Hold 6.99
Citigroup 25 Apr 2025 8.75 (18.24%) Hold 7.20
Jefferies 21 Apr 2025 8.00 (8.11%) Hold 6.51
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
DIVITA CHARLES III - - 0 0
Aggregate Net Quantity 0
Aggregate Net Value ($) 0
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) -
Name Holder Date Type Quantity Price Value ($)
DIVITA CHARLES III Officer 10 Jun 2025 Option execute 156,641 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria